The medical technology company AngioDynamics (NASDAQ: ANGO) announced today that its management team will present at the Goldman Sachs 47th Annual Global Healthcare Conference. The presentation is scheduled for 9:20 AM Eastern Time on June 10th, 2026.
AngioDynamics is a transformative medical technology company focused on restoring healthy blood flow in the vascular system, expanding cancer treatment options, and improving patient quality of life. The company's innovative technologies and devices are used by specialist physicians to address unmet patient needs in fast-growing healthcare markets. Its business comprises Medical Technology and Medical Devices segments. The Medical Technology segment includes the Auryon atherectomy platform for peripheral arteries, the thrombus management platform led by AlphaVac and AngioVac, and the NanoKnife irreversible electroporation ablation system.
According to the company's recently released fiscal 2026 third-quarter results, the Medical Technology segment achieved its sixth consecutive quarter of double-digit growth, with net sales reaching $78.4 million, an 8.9% increase year-over-year. Within this segment, Medical Technology business net sales were $37.3 million, up 19.0% year-over-year, with Auryon sales growing 17.9%, thrombus management sales growing 17.9%, and NanoKnife sales growing 21.0%. The company has raised its full-year fiscal 2026 net sales and adjusted EBITDA guidance for the third consecutive quarter.
The conference presentation will be webcast live and can be accessed via the Investors section of the company's website. A replay will be available at the same location following the live event.
Comments